Medical Data Vision Co., Ltd.
Stock Price Chart
2026/04/24 UpdatedPrice Trend
2026/04/24 UpdatedPrice & Trading Details
2026/04/24 UpdatedPRICE
TRADING
Analyst Recommendations 1 analysts
Updated 2026/06/01Earnings Calendar
Updated 2026/06/01Recent Earnings
| Date | EPS Est. | EPS Actual | Surprise |
|---|---|---|---|
| 2022/02/14 | ¥7.20 | ¥9.92 | +37.8% |
| 2020/02/09 | ¥2.90 | ¥6.06 | +109.0% |
Shareholder Composition
Updated 2026/06/01Major Holders
Updated 2026/06/01| Institution | Ownership | Shares | Change |
|---|---|---|---|
|
Vanguard International Stock Index-Total Intl Stock Indx
|
194.3K | 0.00% | |
|
DFA Japanese Small Company Series
|
149.3K | 0.00% | |
|
Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund
|
116.9K | 0.00% | |
|
DFA International Core Equity Portfolio
|
94.8K | -7.96% | |
|
SPDR (R) Idx Shares-SPDR (R) S&P (R) International Small Cap ETF
|
63.4K | 0.00% | |
|
Vanguard Intl Equity Index Fds-FTSE All World ex U.S.Small Cap Index
|
61.8K | 0.00% |
Dividend History
Updated 2026/06/21| Year | Dividend | Change |
|---|---|---|
| 2024 | ¥7 | 0.0% |
| 2023 | ¥7 | +8.3% |
| 2022 | ¥6 | +7.1% |
| 2021 | ¥6 | +86.7% |
| 2020 | ¥3 | - |
Financial Performance
2026/06/21 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥6,105M | ¥6,419M | ¥5,907M | ¥6,539M |
| Gross Profit | ¥5,030M | ¥5,031M | ¥4,331M | ¥4,553M |
| Operating Income | ¥1,758M | ¥1,771M | ¥4M | ¥349M |
| Pretax Income | ¥1,758M | ¥1,771M | ¥4M | ¥349M |
| Net Income | ¥871M | ¥979M | -¥791M | ¥280M |
| EPS | ¥22.76 | ¥25.63 | -¥20.73 | - |
| Operating Margin | 28.80% | 27.59% | 0.06% | 5.34% |
| Balance Sheet | ||||
| Total Assets | ¥4,897M | ¥6,221M | ¥4,749M | ¥4,778M |
| Total Equity | ¥3,516M | ¥4,251M | ¥3,101M | ¥3,083M |
| Total Liabilities | ¥1,382M | ¥1,970M | ¥1,648M | ¥1,695M |
| Cash | ¥2,265M | ¥3,218M | ¥1,347M | ¥1,713M |
| Interest-bearing Debt | - | - | - | - |
| Equity Ratio | 71.79% | 68.33% | 65.30% | 64.52% |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow | ||||
| Operating CF | ¥911M | ¥1,616M | -¥878M | ¥782M |
| Investing CF | -¥869M | -¥438M | -¥593M | -¥97M |
| Financing CF | -¥979M | -¥225M | -¥400M | -¥319M |
| Free CF | ¥858M | ¥1,586M | -¥1,032M | ¥720M |
| Efficiency | ||||
| ROE | 24.76% | 23.03% | -25.51% | 9.09% |
| ROA | 17.78% | 15.74% | -16.66% | 5.86% |
Latest IR Information
-
Notice of Delisting of Our Shares
The company will be delisted from the Tokyo Stock Exchange as of April 24, 2026, following the approval of a reverse stock split at the shareholders meeting on March 24, 2026.
Read more -
Regarding Matters Concerning the Controlling Shareholder
Nippon Life Insurance Company holds 53.05% of voting rights and plans to make a full subsidiary. SBI Holdings plans to acquire its 38.32% shareholding as treasury stock.
Read more -
Notice Concerning the Issuance of Class A Preferred Shares by Third-Party Allotment and the Reduction of Capital Stock and Capital Surplus
On May 11, 2026, Medical Data Vision Co., Ltd. will issue 1 Class A preferred share by third-party allotment to Nippon Life Insurance Company at 17,249,077,446 yen, and simultaneously reduce capital stock and capital surplus to secure funds for share...
Read more -
Notice Regarding Approval Resolution on Share Consolidation, Abolition of the Unit Share System, and Partial Amendment to the Articles of Incorporation
The total number of outstanding shares will decrease by 37,856,768 shares due to the share consolidation, effective date April 28, 2026. Delisting scheduled for April 24, 2026.
Read more
Latest News (5 items)
-
Average Analyst Rating: none
Average Target Price: ¥420
Rating Score: - (Based on 1 analysts)
※1=Strong Buy, 5=Strong Sell
Company Information
About
Medical Data Vision Co., Ltd., together with its subsidiaries, develops, produces, maintains, and sells medical information integration systems in Japan, Europe, North America, Asia, and Oceania. The company offers data network services; data utilization services; MDV act, an analysis application that enables hospitals to preview hospital management indicators; and Karteco, a personal health record that enables users to independently manage their health and medical information. It also provides research, analysis, and consulting services for various medical data; business consulting services for medical institutions; operation and related services of various medical data; and planning, design, development, and operation of portal websites. The company serves hospitals, medical check centers, companies, and citizens. Medical Data Vision Co., Ltd. was incorporated in 2003 and is headquartered in Chiyoda, Japan. As of February 3, 2026, Medical Data Vision Co., Ltd. operates as a subsidiary of Nippon Life Insurance Company.
